Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
203
-
Total 13F shares, excl. options
-
61,124,372
-
Shares change
-
-1,134,734
-
Total reported value, excl. options
-
$2,935,863,409
-
Value change
-
+$23,562,040
-
Put/Call ratio
-
80.9%
-
Number of buys
-
112
-
Number of sells
-
-90
-
Price
-
$48.03
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2019
259 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q4 2019.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61,124,372 shares
of 80,437,135 outstanding shares and own 76% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (5,470,308 shares), VANGUARD GROUP INC (5,441,640 shares), BlackRock Inc. (4,914,593 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,037,987 shares), RTW INVESTMENTS, LP (3,832,480 shares), FMR LLC (2,422,842 shares), STATE STREET CORP (2,338,946 shares), GREAT POINT PARTNERS LLC (1,750,000 shares), ORBIMED ADVISORS LLC (1,729,200 shares), and JANUS HENDERSON GROUP PLC (1,486,662 shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.